Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2004

01.08.2004 | Clinical Investigation

Delay in diagnosis and outcome of Acanthamoeba keratitis

verfasst von: I. Claerhout, A. Goegebuer, C. Van Den Broecke, Ph. Kestelyn

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the outcome of Acanthamoeba keratitis with respect to the delay in diagnosis.

Methods

A retrospective review of the records of 14 patients treated for Acanthamoeba keratitis was carried out. Delay in diagnosis was correlated with risk factors, clinical presentation, method of diagnosis, final visual acuity and need for penetrating keratoplasty.

Results

Based on the time interval between the first symptoms and the diagnosis of Acanthamoeba keratitis, it appeared that patients could be divided into two groups: an early treatment group (group I), consisting of six patients treated within 18 days of onset of symptoms, and a late treatment group (group II), composed of eight patients treated beyond that time. There were no statistically significant differences between the two groups as far as risk factors, clinical presentation, accuracy of diagnosis and method of diagnosis were concerned, although more extensive and deeper corneal involvement was noted in group II. Improvement in visual acuity following medical therapy was seen in all six patients in the early group and in three (37%) of the eight patients in the late group. One patient in group I needed urgent penetrating keratoplasty for corneal necrosis. In group II, two patients underwent penetrating keratoplasty à chaud to prevent corneal perforation and three patients needed penetrating keratoplasty to restore functional visual acuity.

Conclusion

A diagnostic delay of less than 18 days between onset of symptoms and start of anti-amoebic treatment results in a better final VA after medical treatment and obviates the need for urgent and elective penetrating keratoplasty.
Literatur
1.
Zurück zum Zitat Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P (1993) Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 100:1238–1243PubMed Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P (1993) Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 100:1238–1243PubMed
2.
Zurück zum Zitat Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye 7 (6):719–725PubMed Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye 7 (6):719–725PubMed
3.
Zurück zum Zitat Bialasiewicz AA, Bischoff G, Walter A, Engelmann K, Richard G (2001) [Correlation of 55 samples of contact lens fluid and direct swabbings of the eye surface of symptomatic wearers of contact lenses]. Ophthalmologe 98:747–760CrossRefPubMed Bialasiewicz AA, Bischoff G, Walter A, Engelmann K, Richard G (2001) [Correlation of 55 samples of contact lens fluid and direct swabbings of the eye surface of symptomatic wearers of contact lenses]. Ophthalmologe 98:747–760CrossRefPubMed
4.
Zurück zum Zitat Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH (1995) Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology 102:1369–1373PubMed Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH (1995) Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology 102:1369–1373PubMed
5.
Zurück zum Zitat Devonshire P, Munro FA, Abernethy C, Clark BJ (1993) Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol 77:41–45PubMed Devonshire P, Munro FA, Abernethy C, Clark BJ (1993) Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol 77:41–45PubMed
6.
Zurück zum Zitat Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, Tuft S (1997) Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104:1587–1592PubMed Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, Tuft S (1997) Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104:1587–1592PubMed
7.
Zurück zum Zitat Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 100:105–110PubMed Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 100:105–110PubMed
8.
Zurück zum Zitat Illingworth CD, Cook SD (1996) Acanthamoeba keratitis. Surv Ophthalmol 42:493–508CrossRef Illingworth CD, Cook SD (1996) Acanthamoeba keratitis. Surv Ophthalmol 42:493–508CrossRef
9.
Zurück zum Zitat Illingworth CD, Cook SD, Karabatsas CH, Easty DL (1995) Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 79:1078–1082PubMed Illingworth CD, Cook SD, Karabatsas CH, Easty DL (1995) Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 79:1078–1082PubMed
10.
Zurück zum Zitat Jones DB, Visvesvara GS, Robinson NM (1975) Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 95:221–232PubMed Jones DB, Visvesvara GS, Robinson NM (1975) Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 95:221–232PubMed
11.
Zurück zum Zitat Kremer I, Cohen EJ, Eagle RC, Udell I, Laibson PR (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48PubMed Kremer I, Cohen EJ, Eagle RC, Udell I, Laibson PR (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48PubMed
12.
Zurück zum Zitat Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74:133–135PubMed Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74:133–135PubMed
13.
Zurück zum Zitat Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191PubMed Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191PubMed
14.
Zurück zum Zitat Lindquist TD (1998) Treatment of Acanthamoeba keratitis. Cornea 17:11–16PubMed Lindquist TD (1998) Treatment of Acanthamoeba keratitis. Cornea 17:11–16PubMed
15.
Zurück zum Zitat Mannis MJ, Tamaru R, Roth AM, Burns M, Thirkill C (1986) Acanthamoeba sclerokeratitis: determing diagnostic criteria. Arch Ophthalmol 104:1313–1317PubMed Mannis MJ, Tamaru R, Roth AM, Burns M, Thirkill C (1986) Acanthamoeba sclerokeratitis: determing diagnostic criteria. Arch Ophthalmol 104:1313–1317PubMed
16.
Zurück zum Zitat Mathers WD, Sutphin JE, et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142PubMed Mathers WD, Sutphin JE, et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142PubMed
17.
Zurück zum Zitat Moore MB, McCulley JP (1989) Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 73:271–275PubMed Moore MB, McCulley JP (1989) Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 73:271–275PubMed
18.
Zurück zum Zitat Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD (1974) Amoebic infection of the eye. Lancet 2:1537–1540CrossRefPubMed Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD (1974) Amoebic infection of the eye. Lancet 2:1537–1540CrossRefPubMed
19.
Zurück zum Zitat Radford CF, Bacon AS, Dart JK, Minassian DC (1995) Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310:1567–1570PubMed Radford CF, Bacon AS, Dart JK, Minassian DC (1995) Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310:1567–1570PubMed
20.
Zurück zum Zitat Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86:536–542CrossRefPubMed Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86:536–542CrossRefPubMed
21.
Zurück zum Zitat Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10PubMed Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10PubMed
22.
Zurück zum Zitat Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M (1996) Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10 (4):413–421PubMed Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M (1996) Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10 (4):413–421PubMed
23.
Zurück zum Zitat Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108CrossRefPubMed Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108CrossRefPubMed
24.
Zurück zum Zitat Tabin G, Taylor H, Snibson G, Murchison A, Gushchin A, Rogers S (2001) Atypical presentation of Acanthamoeba keratitis. Cornea 20:757–759CrossRefPubMed Tabin G, Taylor H, Snibson G, Murchison A, Gushchin A, Rogers S (2001) Atypical presentation of Acanthamoeba keratitis. Cornea 20:757–759CrossRefPubMed
25.
Zurück zum Zitat Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782PubMed Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782PubMed
Metadaten
Titel
Delay in diagnosis and outcome of Acanthamoeba keratitis
verfasst von
I. Claerhout
A. Goegebuer
C. Van Den Broecke
Ph. Kestelyn
Publikationsdatum
01.08.2004
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 8/2004
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-003-0805-7

Weitere Artikel der Ausgabe 8/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2004 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.